Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
about
Blood markers of oxidative stress in Alzheimer's diseaseIsotope-differentiated binding energy shift tags (IDBEST) for improved targeted biomarker discovery and validation.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's diseaseProteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Biological markers and Alzheimer disease: a canadian perspectiveProteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.An alternative view of the proposed alternative activities of hemopexin.Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas DiseaseAdditive effects of mitochondrion-targeted cytochrome CYP2E1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes.Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseasesTwo-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.Alzheimer's disease: are blood and brain markers related? A systematic review.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.S-Nitrosylation Proteome Profile of Peripheral Blood Mononuclear Cells in Human Heart FailureProtein Oxidation in the Lungs of C57BL/6J Mice Following X-Irradiation.Proteomic research in psychiatry.Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment.Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Mass spectrometry and redox proteomics: applications in disease.Early induction of oxidative stress in a mouse model of Alzheimer's disease with heme oxygenase activity.Identification of oxidative modifications of hemopexin and their predicted physiological relevance.Effects of L-arginine and L-NAME on chronic partial bladder outlet obstruction in rabbit.Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer's Disease.Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer's disease.
P2860
Q27021625-6E41D40D-2294-4CE4-9DB8-C4E6420F7B08Q33217472-2A934390-49F8-4E1C-853F-8CB807199CACQ33237201-5517A112-85A2-4BE7-B3E8-FCF381995E2DQ33266027-53B3A12D-3F5F-44DB-A832-B1CB84E47B3BQ33666765-D439CA33-B6C6-493F-B108-10DF64FFBC83Q34089784-962BE3EF-8104-4B8E-828A-7777B4D90D7CQ34112124-A650FC0F-6B78-47CB-93E0-E26EF67BB6FBQ34250328-70968A76-06B0-4D42-B939-243410EA8663Q34627609-5E10A299-1B36-4587-96AB-6E41B1CF5C6EQ35031967-426FA09B-9B99-4041-804A-F1E7974DC979Q35191570-B3AA04D6-FB1A-40DD-A852-D8AE35144E90Q35937562-2EB71456-E3C6-497E-966E-97F01575A4D7Q35940000-739FCEA9-85A1-44A8-BB12-ABEF92086986Q36023238-829A5E33-1542-4B79-975C-4FBD8A6F6B79Q36525162-4CC89DAB-BEA0-4B20-AD56-4409C1EC88F0Q36846943-9BC74390-E736-4972-A703-FA9ADE898957Q36966044-4C0252AB-0445-4226-8AED-A5D09D077C5AQ37068847-AB476F05-FE3B-4B8A-827C-D21290BBAB6BQ37223016-E079C188-FED8-44B4-8632-CEFC5E230807Q37566453-F31FE5E0-1669-49BC-BA06-F850DC372E8CQ37689362-93783911-BEC5-42DA-BF64-1775588DB8F2Q37755075-06E22AC8-39C4-4E2A-97CE-092DB09EAAACQ37766494-046D56C9-3DFB-4093-B569-C2F589FC4F97Q38027217-ED31DD51-4D88-4E40-A88D-6A37F982D503Q38037157-6DF7481E-5809-422B-9D2E-793D69498C70Q38060574-CAE5CE8A-23B0-4424-8284-812818AFCDA7Q38125769-E297B389-5C5F-4639-983C-B33883B2D975Q38220377-930FAFCA-2B26-4690-8D13-9594935AED6BQ42733175-E8AA4B14-26B9-4B6F-B532-971A8825816EQ46353874-39A4092C-ED2A-48AD-8D4F-075110740837Q46956725-695537D3-206C-4A32-9C94-4EE3E51D0AD5Q47865422-2C88C653-3BE4-4E96-90A8-7EA73D5ACD67Q53367065-BE9512AA-CD4D-40AA-9D33-DB7DA4EA1D4D
P2860
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@ast
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@en
type
label
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@ast
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@en
prefLabel
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@ast
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@en
P2093
P356
P1433
P1476
Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.
@en
P2093
Han-Ling Yu
Howard Bergman
Howard M Chertkow
Hyman M Schipper
P304
P356
10.1002/PMIC.200300475
P577
2003-11-01T00:00:00Z